San Antonio, TX, United States of America

John Elson

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by John Elson in Critical Care Systems

Introduction

John Elson is an accomplished inventor based in San Antonio, TX (US), known for his significant contributions to the field of medical technology. With a total of three patents to his name, Elson has focused on developing advanced systems that enhance patient care during critical situations.

Latest Patents

Elson's latest patents include innovations in autonomous critical care systems and integrated combat casualty care systems. These systems, devices, and methods are designed for monitoring and treating patients en route to medical facilities. The critical care unit is equipped with at least one patient monitoring device that collects physiological data about the patient. Additionally, it includes patient treatment devices that receive treatment instructions from the critical care unit. A two-way communications device facilitates interaction between the critical care unit and a remote communications terminal, allowing for real-time data exchange and treatment guidance.

Career Highlights

Throughout his career, John Elson has demonstrated a commitment to improving medical care through technology. His work has been instrumental in developing systems that not only monitor patients but also provide critical treatment instructions, thereby enhancing the efficiency of emergency medical services.

Collaborations

Elson has collaborated with notable colleagues such as Mark Darrah and Cesar Gradilla, contributing to the advancement of medical technologies and innovations.

Conclusion

John Elson's work in autonomous critical care systems exemplifies the intersection of technology and healthcare. His inventions are paving the way for improved patient outcomes in emergency situations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…